Cargando…

Astragaloside in cancer chemoprevention and therapy

Tumor chemoprevention and treatment are two approaches aimed at improving the survival of patients with cancers. An ideal anti-tumor drug is that which not only kills tumor cells but also alleviates tumor-causing risk factors, such as precancerous lesions, and prevents tumor recurrence. Chinese herb...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaning, Zhang, Zhuo, Cheng, Zhaohua, Xie, Wei, Qin, Hanjiao, Sheng, Jiyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278710/
https://www.ncbi.nlm.nih.gov/pubmed/37075760
http://dx.doi.org/10.1097/CM9.0000000000002661
_version_ 1785060534433873920
author Wang, Yaning
Zhang, Zhuo
Cheng, Zhaohua
Xie, Wei
Qin, Hanjiao
Sheng, Jiyao
author_facet Wang, Yaning
Zhang, Zhuo
Cheng, Zhaohua
Xie, Wei
Qin, Hanjiao
Sheng, Jiyao
author_sort Wang, Yaning
collection PubMed
description Tumor chemoprevention and treatment are two approaches aimed at improving the survival of patients with cancers. An ideal anti-tumor drug is that which not only kills tumor cells but also alleviates tumor-causing risk factors, such as precancerous lesions, and prevents tumor recurrence. Chinese herbal monomers are considered to be ideal treatment agents due to their multi-target effects. Astragaloside has been shown to possess tumor chemoprevention, direct anti-tumor, and chemotherapeutic drug sensitization effects. In this paper, we review the effects of astragaloside on tumor prevention and treatment and provide directions for further research.
format Online
Article
Text
id pubmed-10278710
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102787102023-06-20 Astragaloside in cancer chemoprevention and therapy Wang, Yaning Zhang, Zhuo Cheng, Zhaohua Xie, Wei Qin, Hanjiao Sheng, Jiyao Chin Med J (Engl) Review Article Tumor chemoprevention and treatment are two approaches aimed at improving the survival of patients with cancers. An ideal anti-tumor drug is that which not only kills tumor cells but also alleviates tumor-causing risk factors, such as precancerous lesions, and prevents tumor recurrence. Chinese herbal monomers are considered to be ideal treatment agents due to their multi-target effects. Astragaloside has been shown to possess tumor chemoprevention, direct anti-tumor, and chemotherapeutic drug sensitization effects. In this paper, we review the effects of astragaloside on tumor prevention and treatment and provide directions for further research. Lippincott Williams & Wilkins 2023-04-18 2023-05-20 /pmc/articles/PMC10278710/ /pubmed/37075760 http://dx.doi.org/10.1097/CM9.0000000000002661 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review Article
Wang, Yaning
Zhang, Zhuo
Cheng, Zhaohua
Xie, Wei
Qin, Hanjiao
Sheng, Jiyao
Astragaloside in cancer chemoprevention and therapy
title Astragaloside in cancer chemoprevention and therapy
title_full Astragaloside in cancer chemoprevention and therapy
title_fullStr Astragaloside in cancer chemoprevention and therapy
title_full_unstemmed Astragaloside in cancer chemoprevention and therapy
title_short Astragaloside in cancer chemoprevention and therapy
title_sort astragaloside in cancer chemoprevention and therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278710/
https://www.ncbi.nlm.nih.gov/pubmed/37075760
http://dx.doi.org/10.1097/CM9.0000000000002661
work_keys_str_mv AT wangyaning astragalosideincancerchemopreventionandtherapy
AT zhangzhuo astragalosideincancerchemopreventionandtherapy
AT chengzhaohua astragalosideincancerchemopreventionandtherapy
AT xiewei astragalosideincancerchemopreventionandtherapy
AT qinhanjiao astragalosideincancerchemopreventionandtherapy
AT shengjiyao astragalosideincancerchemopreventionandtherapy